Filtered By:
Specialty: Cardiology
Condition: Chronic Obstructive Pulmonary

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 145 results found since Jan 2013.

Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
CONCLUSIONS: -T2MI is common and associated with poor prognosis. Studies evaluating treatment strategies for management of T2MI are needed.Clinical Trial Registration -https://clinicaltrials.gov/ct2/show/NCT00842868, Clinical Trials.Gov # NCT00842868. PMID: 27881568 [PubMed - as supplied by publisher]
Source: Circulation - November 20, 2016 Category: Cardiology Authors: Gaggin HK, Liu Y, Lyass A, van Kimmenade RR, Motiwala SR, Kelly N, Mallick A, Gandhi PU, Ibrahim NE, Simon M, Bhardwaj A, Belcher A, Harisiades JE, Massaro JM, D'Agostino RB, Januzzi JL Tags: Circulation Source Type: research

Is SYNTAX Score Predictive of Atrial Fibrillation after On-Pump Coronary Artery Bypass Graft Surgery?
CONCLUSION: The SYNTAX score level was independently associated with the development of AF after CABG. PMID: 27826338 [PubMed - in process]
Source: Korean Circulation Journal - November 11, 2016 Category: Cardiology Tags: Korean Circ J Source Type: research

Return to the Workforce Following First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study.
CONCLUSIONS: -Patients in the workforce prior to HF hospitalization had low mortality but high risk of detachment from the workforce one year later. Young age, male sex, and higher level of education were predictors of return to work. PMID: 27507406 [PubMed - as supplied by publisher]
Source: Circulation - August 8, 2016 Category: Cardiology Authors: Rørth R, Wong C, Kragholm K, Fosbøl E, Mogensen UM, Lamberts M, Petrie MC, Jhund PS, Gerds TA, Torp-Pedersen C, Gislason GH, McMurray JJ, Køber L, Kristensen SL Tags: Circulation Source Type: research

The role of HATCH score in predicting the success rate of sinus rhythm following electrical cardioversion of atrial fibrillation.
CONCLUSIONS: HATCH score is useful in predicting short-term success of EC at early stages for patients with AF for whom the use of a rhythm-control strategy is planned. PMID: 27040017 [PubMed - as supplied by publisher]
Source: Polish Heart Journal - April 3, 2016 Category: Cardiology Authors: Emren SV, Koacabaş U, Duygu H, Levent F, Şimşek EÇ, Yapan Emrem Z, Tülüce S Tags: Kardiol Pol Source Type: research

Prediction of atrial fibrillation development and progression: Current perspectives.
Abstract Atrial fibrillation (AF) is the most common arrhythmia in clinical practice. Several conventional and novel predictors of AF development and progression (from paroxysmal to persistent and permanent types) have been reported. The most important predictor of AF progression is possibly the arrhythmia itself. The electrical, mechanical and structural remodeling determines the perpetuation of AF and the progression from paroxysmal to persistent and permanent forms. Common clinical scores such as the hypertension, age ≥ 75 years, transient ischemic attack or stroke, chronic obstructive pulmonary disease, and ...
Source: World Journal of Cardiology - March 25, 2016 Category: Cardiology Authors: Vlachos K, Letsas KP, Korantzopoulos P, Liu T, Georgopoulos S, Bakalakos A, Karamichalakis N, Xydonas S, Efremidis M, Sideris A Tags: World J Cardiol Source Type: research

Off-Hour Admission and Mortality Risk for 28 Specific Diseases: A Systematic Review and Meta-Analysis of 251 Cohorts Epidemiology
Conclusions Off-hour admission is associated with increased mortality risk, and the associations varied substantially for different diseases. Specialists, nurses, as well as hospital administrators and health policymakers can take these findings into consideration to improve the quality and continuity of medical services.
Source: JAHA:Journal of the American Heart Association - March 17, 2016 Category: Cardiology Authors: Zhou, Y., Li, W., Herath, C., Xia, J., Hu, B., Song, F., Cao, S., Lu, Z. Tags: Epidemiology, Risk Factors, Health Services, Meta Analysis, Mortality/Survival Source Type: research

Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF Arrhythmia and Electrophysiology
Conclusions In a large population of patients anticoagulated for nonvalvular atrial fibrillation, 7 in 10 deaths were cardiovascular, whereas <1 in 10 deaths were caused by nonhemorrhagic stroke or systemic embolism. Optimal prevention and treatment of heart failure, renal impairment, chronic obstructive pulmonary disease, and diabetes may improve survival. Clinical Trial Registration URL: https://www.clinicaltrials.gov/. Unique identifier: NCT00403767.
Source: JAHA:Journal of the American Heart Association - March 7, 2016 Category: Cardiology Authors: Pokorney, S. D., Piccini, J. P., Stevens, S. R., Patel, M. R., Pieper, K. S., Halperin, J. L., Breithardt, G., Singer, D. E., Hankey, G. J., Hacke, W., Becker, R. C., Berkowitz, S. D., Nessel, C. C., Mahaffey, K. W., Fox, K. A. A., Califf, R. M., for the Tags: Atrial Fibrillation, Sudden Cardiac Death, Heart Failure, Intracranial Hemorrhage, Ischemic Stroke Arrhythmia and Electrophysiology Source Type: research

0484: The LEADERS FREE Trial: a double blind randomized comparison of a BMS and a polymer-free Drug Coated Stent (DCS) in 2,466 patients at high bleeding risk and treated with one month DAPT only
Conclusion The trial focuses on a never previously studied high bleeding risk population characterized by advanced age and more comorbid conditions. It is the 1st evaluation of a DCS with clinical endpoints and comprises the shortest ever DAPT course with an active stent to be evaluated for both safety and efficacy.
Source: Archives of Cardiovascular Diseases Supplements - March 7, 2016 Category: Cardiology Source Type: research

Prognostic and symptomatic benefits with ivabradine: lessons from the SHIFT trial
Ivabradine, a funny current (If) inhibitor, has been developed for symptomatic therapy of angina and in chronic heart failure (CHF) with low ejection fraction. A large outcome trial, SHIFT (Systolic Heart Failure Treatment with the If inhibitor ivabradine trial), was conducted in patients with EF ≤ 35% in sinus rhythm and increased heart rate ≥70 b.p.m. It demonstrated that the addition of this new compound to the best possible contemporary therapy, including beta-blockers, was associated with a 18% relative risk reduction in the occurrence of cardiovascular mortality or hospitalization for worsening heart failure (H...
Source: European Journal of Heart Failure Supplements - December 16, 2015 Category: Cardiology Authors: Komajda, M. Tags: Articles Source Type: research

Cardiac risk stratification in patients undergoing endovascular aortic repair.
Authors: Biagi P, de Donato G, Setacci C Abstract Endovascular aortic repair (EVAR) for abdominal aortic aneurysms (AAA) is the preferred first treatment option in case of patients with advanced age and/or fit anatomy owing to shorter length of in hospital staying, less complications or laparotomy-related re- interventions, and lower initial costs. Although it is a less-invasive intervention, EVAR entails a risk similar to that of open aortic procedures for medical comorbidities, and a perioperative clinical evaluation is mandatory to minimize the early and late cardiovascular risk. In this brief review the determi...
Source: Minerva Cardioangiologica - November 18, 2015 Category: Cardiology Tags: Minerva Cardioangiol Source Type: research

Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial Coronary Heart Disease
Conclusions In this post-hoc analysis, COPD patients experienced high rates of ischemic events. Ticagrelor versus clopidogrel reduced and substantially decreased the absolute risk of ischemic events (5.8%) in COPD patients, without increasing overall major bleeding events. The benefit-risk profile supports the use of ticagrelor in patients with ACS and concomitant COPD. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT00391872.
Source: JAHA:Journal of the American Heart Association - October 9, 2015 Category: Cardiology Authors: Andell, P., James, S. K., Cannon, C. P., Cyr, D. D., Himmelmann, A., Husted, S., Keltai, M., Koul, S., Santoso, A., Steg, P. G., Storey, R. F., Wallentin, L., Erlinge, D., the PLATO Investigators Tags: Coronary Heart Disease Source Type: research

Influence of Cardiovascular and Noncardiovascular Co-morbidities on Outcomes and Treatment Effect of Heart Rate Reduction With in Stable Heart Failure (from the SHIFT Trial)
Incidence of chronic heart failure (HF) increases with age and cardiovascular (CV) morbidity. Co-morbidities increase hospitalization and mortality in HF, and non-CV co-morbidities may lead to preventable hospitalizations. We studied the impact of co-morbidities on mortality and morbidity in Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial, and investigated whether the impact of ivabradine was affected by co-morbidities. We analyzed the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trialpopulation, with moderate-to-severe HF and left ventricular dysfunction (in sinus rhythm with h...
Source: The American Journal of Cardiology - October 5, 2015 Category: Cardiology Authors: Michael Böhm, Michele Robertson, Ian Ford, Jeffrey S. Borer, Michel Komajda, Ingrid Kindermann, Christoph Maack, Mitja Lainscak, Karl Swedberg, Luigi Tavazzi Tags: Heart Failure Source Type: research

Influence of Cardiovascular and Non-Cardiovascular Comorbidities on Outcomes and Treatment Effect of Heart Rate Reduction with Ivabradine in Stable Heart Failure – (from the SHIFT trial)
Incidence of chronic heart failure (HF) increases with age and cardiovascular morbidity. Comorbidities increase hospitalization and mortality in HF, and non-cardiovascular comorbidities may lead to preventable hospitalizations. We studied the impact of comorbidities on mortality and morbidity in SHIFT, and investigated whether the impact of ivabradine was affected by comorbidities. We analyzed the SHIFT population, with moderate to severe HF and left ventricular dysfunction (in sinus rhythm with resting heart rate ≥70 bpm), according to comorbidity: chronic obstructive pulmonary disease, diabetes mellitus, anemia, stroke...
Source: The American Journal of Cardiology - October 5, 2015 Category: Cardiology Authors: Michael Böhm, Michele Robertson, Ian Ford, Jeffrey S. Borer, Michel Komajda, Ingrid Kindermann, Christoph Maack, Mitja Lainscak, Karl Swedberg, Luigi Tavazzi Source Type: research

Chronic Obstructive Pulmonary Disease in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial
Comorbid chronic obstructive pulmonary disease (COPD) is associated with poor outcomes among patients with cardiovascular disease. The risks of stroke and mortality associated with COPD among patients with atrial fibrillation are not well understood.
Source: International Journal of Cardiology - September 22, 2015 Category: Cardiology Authors: Michael T. Durheim, Derek D. Cyr, Renato D. Lopes, Laine E. Thomas, Wayne M. Tsuang, Bernard J. Gersh, Claes Held, Lars Wallentin, Christopher B. Granger, Scott M. Palmer, Sana M. Al-Khatib Source Type: research

Work Stress as a Risk Factor for Cardiovascular Disease
Abstract The role of psychosocial work stress as a risk factor for chronic disease has been the subject of considerable debate. Many researchers argue in support of a causal connection while others remain skeptical and have argued that the effect on specific health conditions is either negligible or confounded. This review of evidence from over 600,000 men and women from 27 cohort studies in Europe, the USA and Japan suggests that work stressors, such as job strain and long working hours, are associated with a moderately elevated risk of incident coronary heart disease and stroke. The excess risk for exposed indi...
Source: Current Cardiology Reports - August 3, 2015 Category: Cardiology Source Type: research